Prevalence of abnormal urine drug tests during COVID-19 pandemic in the cancer patient population: retrospective study
Description
Background: Opioid misuse is a persistent concern, heightened by the COVID-19 pandemic. This study examines the risk factors contributing to elevated rates of abnormal urine drug tests (UDTs) in the cancer pain patient population during COVID-19
